Esperanto SRL
0.6 FTEThe score of Esperanto shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Esperanto's annual accounts
| 2025 | |
|---|---|
| Net result | 53,288 € |
| Equity | 58,288 € |
| Cash | 40,469 € |
| EBITDA | 143,770 € |
| Total assets | 573,018 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 08 Oct 2026
Esperanto's financial analysis
- Solvency10.2%sector median: 44.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Esperanto
Esperanto's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1018.104.080
- VAT number
- BE1018104080
- Peppol
- Registered · 0208:1018104080 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 31 Dec 2024
- Registered office
- 8880 Ledegem
- Size
- Micro · 0.6 FTE
- Latest accounts
- 2025 · filed on 08 Oct 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Esperanto (SRL) has been based in Ledegem since 2024, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 53,288 € and equity of 58,288 €; its revenue is not published. With 0.6 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 10.2%, below the median of its sector (44.0%).
Companies similar to Esperanto
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie DE Neef - Duez Retail sale of pharmaceutical products Mons · balance sheet 181,026 €
- Apotheek Vanduynslager Retail sale of pharmaceutical products Wevelgem · balance sheet 577,436 €
- Emanuel - VAN Hauwermeiren Retail sale of pharmaceutical products Dendermonde · balance sheet 588,306 €
- Farmadec Retail sale of pharmaceutical products Asse · balance sheet 554,731 €
- Vereenooghe OST Retail sale of pharmaceutical products Ostend · balance sheet 553,755 €
- Caro Pharma Retail sale of pharmaceutical products Erquelinnes · balance sheet 593,057 €
- Antwer Retail sale of pharmaceutical products Wervik · balance sheet 548,543 €
- Avanu Retail sale of pharmaceutical products Aalst · balance sheet 544,416 €
Frequently asked questions about Esperanto
What is the revenue of Esperanto?
Esperanto files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Esperanto?
In Belgium, the VAT number is the company number prefixed with BE: BE1018104080 for Esperanto, if the company is VAT-registered. Its company number (CBE) is 1018.104.080.
Where is the registered office of Esperanto?
According to the CBE register, the registered office of Esperanto is in 8880 Ledegem.
What is the equity of Esperanto?
At the close of the 2025 financial year, the equity of Esperanto amounts to 58,288 €, a solvency of 10.2% of total assets.
How many people work at Esperanto?
0.6 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Esperanto?
The register lists 1 active mandates at Esperanto. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Esperanto
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →